Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05728268
Status:
RECRUITING
Last Update Posted:
2023-02-15
First Post:
2023-02-04
Brief Title:
Neoadjuvant Dose-dense Chemotherapy for HRHER2- Breast Cancer Patients With High Proliferation Index
Sponsor:
Shantou Central Hospital
Organization:
Shantou Central Hospital
Organization Data
Organization:
Shantou Central Hospital
Class:
OTHER
Study ID:
ShantouCH02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shantou Central Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Zhiyong Wu
Responsible Party Title:
Dr
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Shantou Central Hospital
Old Name:
None
Old Organization:
None